FLT3 receptor antagonists for the treatment or the prevention of pain disorders
US9765339B2 · kind B2 · utility
1Cited by
0References
6Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Jul 8, 2015 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | Jul 8, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/91205
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to FLT3 receptor antagonists or inhibitors of FLT3 receptor gene expression for the treatment or the prevention of pain disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.